Karyopharm Therapeutics Inc (NASDAQ: KPTI) – Not A Clear Buying Opportunity?
Karyopharm Therapeutics Inc (KPTI) concluded trading on Thursday at a closing price of $0.99, with 8.36 million shares of worth about $8.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.35% during that period and on October 31, 2024 the price saw a […]
An Important Check-Up On Karyopharm Therapeutics Inc (NASDAQ: KPTI)
Karyopharm Therapeutics Inc (KPTI) concluded trading on Wednesday at a closing price of $0.88, with 3.07 million shares of worth about $2.7 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -31.21% during that period and on October 02, 2024 the price saw a […]
Value Hunters: Look To Karyopharm Therapeutics Inc (KPTI)
Currently, there are 113.21M common shares owned by the public and among those 106.32M shares have been available to trade. Insiders at the company have transacted a total of 37 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 8 of these insider trades were purchases, […]
Karyopharm Therapeutics Inc (NASDAQ: KPTI) Stock In Prove Me State
The Vanguard Group, Inc. has recently announced that it has increased stake in Karyopharm Therapeutics Inc (NASDAQ:KPTI) by 2.37%. After grabbing 8.59 million shares, the institutional investor is now in possession of 0.2 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.50% having worth around $6.62 million. […]
